🔎 Trials Near Me

መነሻ › አኩት ሊምፎብላስቲክ ሊውኬሚያ › ማሳቹሴትስ

በማሳቹሴትስ ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ ክሊኒካዊ ጥናቶች

ለአኩት ሊምፎብላስቲክ ሊውኬሚያ የሚደረጉ 15 ጥናቶች በማሳቹሴትስ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በማሳቹሴትስ ውስጥ ያሉ ከተሞች

Official study text (English)

A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...

  • Dana-Farber/Boston Children s Hospital, Boston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ1 እስከ 25 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05621291

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ16 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT03104491

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 22 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04726241

ALL Backbone in AYAs

  • Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 51 · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07227584

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

  • Children's Hospital Corporation d/b/a Boston Children's Hospital, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
1 Day – 17 Years · ሁሉም ጾታዎች · የተሻሻለው በ14 ኦገስ 2026 · NCT06274788

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

  • Brigham and Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ28 ጁላይ 2026 · NCT07020533

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Tufts Medical Center, Boston
  • Beth Israel Deaconess, Boston
  • Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT01351545

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT01790152

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

  • Dana Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 13 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT04771572

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  • Massachusetts General Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ማርች 2026 · NCT04988555

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 66 · ሁሉም ጾታዎች · የተሻሻለው በ17 ማርች 2026 · NCT06859424

Venetoclax Basket Trial for High Risk Hematologic Malignancies

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT05292664

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

  • DFCI/BWH Brigham and Women's Hospital, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 2ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ10 ማርች 2026 · NCT06059391

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ኤፕሪ 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

  • Dana-Farber Cancer Institute, Boston
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ6 ዲሴም 2024 · NCT05476770

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።